Investigative Treatment for Advanced Prostate Cancer Uses Targeted Approach

Video

The investigative therapy targets a specific molecule that is generally only expressed on the prostate cancer cell, according to a recent interview.

New research presented at the American Society of Clinical Oncology 2021 annual meeting has found encouraging results with the use of 177Lu-PSMA-617 in patients with advanced prostate cancer.

Researcher Michael Morris, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, said any kind of cancer therapy should be as targeted as possible in order to attack cancer cells while avoiding healthy cells. Therapy with 177Lu-PSMA-617 is very precise, Morris said, because it targets a specific molecule that is generally only expressed on the prostate cancer cell.

Related Videos
Image credit: Krakenimages.com | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
3D illustration of heart
Model of a heart
Man experiencing heart pain
3D illustration of heart
Patient with diabetes testing blood sugar levels
© 2023 MJH Life Sciences

All rights reserved.